Clearance and Persistence of Hepatitis C Virus in a Tunisian Population: Association with HLA Class I and Class II

Human leukocyte antigens (HLAs) of class I and class II are reported to influence the outcome of hepatitis C virus (HCV) infection. The aim of this study was to assess the role of HLA class I and class II in influencing spontaneous viral clearance or persistence in HCV-infected patients. HLA class I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Viral Immunology 2007-06, Vol.20 (2), p.312-319
Hauptverfasser: Ksiaa, Leila, Ayed-Jendoubi, Saloua, Sfar, Imen, Gorgi, Yousr, Najjar, Houda Aouadi Tawfik, Abdallah, Taieb Ben, Ayed, Khaled
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 319
container_issue 2
container_start_page 312
container_title Viral Immunology
container_volume 20
creator Ksiaa, Leila
Ayed-Jendoubi, Saloua
Sfar, Imen
Gorgi, Yousr
Najjar, Houda Aouadi Tawfik
Abdallah, Taieb Ben
Ayed, Khaled
description Human leukocyte antigens (HLAs) of class I and class II are reported to influence the outcome of hepatitis C virus (HCV) infection. The aim of this study was to assess the role of HLA class I and class II in influencing spontaneous viral clearance or persistence in HCV-infected patients. HLA class I (A and B) typing was performed by lymphocytotoxicity test and HLA class II ( DRB1 ) was determined by low-resolution PCR-SSP (polymerase chain reaction amplification with sequencespecific primers) for 99 subjects (48 men and 51 women). Of these, 75 had chronic infection and 24 had viral clearance. No significant differences were observed between individuals with spontaneous viral clearance or chronic HCV infection for age, sex, source of infection, and risk factors. HLAB-w35 and HLA-DRB1*08 occurred more frequently in those with viral clearance (21.7 and 16.6%, respectively) compared with those with chronic infection (5.5 and 2.6%; p < 0.04 and p < 0.01, respectively). DRB1*15 occurred more often in those with chronic infection (29.3%) compared with those with viral clearance (16.66%), but the difference did not reach statistical significance. These results support the hypothesis that specific HLA class I and class II alleles might influence the clearance or persistence of HCV infection. Both Bw35 and DRB1*08 are associated with clearance of circulating HCV whereas DRB1*15 appears to predispose to progression of liver disease in Tunisian patients. Taken together, our results and those previously reported suggest that HLA associations with the outcome of hepatitis C viremia vary in relation to the ethnicity of the population studied. Further prospective studies of larger cohorts of HCV-infected subjects are needed to evaluate, in different populations, the role of specific HLA class I and class II alleles in the outcome of HCV infection.
doi_str_mv 10.1089/vim.2006.0060
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19736936</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1304104371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-3dc2e109d2f07ea8a848d728a134a33be4352717fb01d43a7ea871e82cd4e4553</originalsourceid><addsrcrecordid>eNqFkU1r2zAYgMVYWdN0x12H2GE3p_qyJO8WTNcEAu2h7VUo9mum4siZXnuj_752alrYZQd9vOLhAfEQ8oWzFWe2uPoTDivBmF6Ni30gC57nJrOF0R_JglkrMitUfk4uEJ8YY1Zb-Ymcc6OZtMosSCpb8MnHCqiPNb2DhAF7mOauoRs4-j70AWlJH0MakIZIPb0fYsDgI73rjkM7El38QdeIXRVOA_0b-l90s1vTsvWIdHtyz_ftJTlrfIvweT6X5OHn9X25yXa3N9tyvcsqaU2fyboSwFlRi4YZ8NZbZWsjrOdSeSn3oGQuDDfNnvFaST8xhoMVVa1A5blcku-v3mPqfg-AvTsErKBtfYRuQGeY1row7L8gL4zUhdQj-O0f8KkbUhw_4QQvcq2MECOUvUJV6hATNO6YwsGnZ8eZm5K5MZmbkrkp2ch_naXD_gD1Oz03ehdOzz7GNsAeUv8Gzjozbk5yIV8A_KSf3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>219564722</pqid></control><display><type>article</type><title>Clearance and Persistence of Hepatitis C Virus in a Tunisian Population: Association with HLA Class I and Class II</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>Wiley Online Library Free Content</source><source>IngentaConnect Free/Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Ksiaa, Leila ; Ayed-Jendoubi, Saloua ; Sfar, Imen ; Gorgi, Yousr ; Najjar, Houda Aouadi Tawfik ; Abdallah, Taieb Ben ; Ayed, Khaled</creator><creatorcontrib>Ksiaa, Leila ; Ayed-Jendoubi, Saloua ; Sfar, Imen ; Gorgi, Yousr ; Najjar, Houda Aouadi Tawfik ; Abdallah, Taieb Ben ; Ayed, Khaled</creatorcontrib><description>Human leukocyte antigens (HLAs) of class I and class II are reported to influence the outcome of hepatitis C virus (HCV) infection. The aim of this study was to assess the role of HLA class I and class II in influencing spontaneous viral clearance or persistence in HCV-infected patients. HLA class I (A and B) typing was performed by lymphocytotoxicity test and HLA class II ( DRB1 ) was determined by low-resolution PCR-SSP (polymerase chain reaction amplification with sequencespecific primers) for 99 subjects (48 men and 51 women). Of these, 75 had chronic infection and 24 had viral clearance. No significant differences were observed between individuals with spontaneous viral clearance or chronic HCV infection for age, sex, source of infection, and risk factors. HLAB-w35 and HLA-DRB1*08 occurred more frequently in those with viral clearance (21.7 and 16.6%, respectively) compared with those with chronic infection (5.5 and 2.6%; p &lt; 0.04 and p &lt; 0.01, respectively). DRB1*15 occurred more often in those with chronic infection (29.3%) compared with those with viral clearance (16.66%), but the difference did not reach statistical significance. These results support the hypothesis that specific HLA class I and class II alleles might influence the clearance or persistence of HCV infection. Both Bw35 and DRB1*08 are associated with clearance of circulating HCV whereas DRB1*15 appears to predispose to progression of liver disease in Tunisian patients. Taken together, our results and those previously reported suggest that HLA associations with the outcome of hepatitis C viremia vary in relation to the ethnicity of the population studied. Further prospective studies of larger cohorts of HCV-infected subjects are needed to evaluate, in different populations, the role of specific HLA class I and class II alleles in the outcome of HCV infection.</description><identifier>ISSN: 0882-8245</identifier><identifier>EISSN: 1557-8976</identifier><identifier>EISSN: 1365-2567</identifier><identifier>DOI: 10.1089/vim.2006.0060</identifier><identifier>PMID: 17603847</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Aged ; Alleles ; Brief Report ; Female ; Genes, MHC Class I ; Genes, MHC Class II ; Genotype ; Hepacivirus - immunology ; Hepacivirus - isolation &amp; purification ; Hepatitis C virus ; Hepatitis C, Chronic - ethnology ; Hepatitis C, Chronic - genetics ; Hepatitis C, Chronic - immunology ; Hepatitis C, Chronic - virology ; Histocompatibility Antigens Class I ; Histocompatibility Antigens Class II ; Humans ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; Tunisia - epidemiology ; Viral Load</subject><ispartof>Viral Immunology, 2007-06, Vol.20 (2), p.312-319</ispartof><rights>Mary Ann Liebert, Inc.</rights><rights>(©) Mary Ann Liebert, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-3dc2e109d2f07ea8a848d728a134a33be4352717fb01d43a7ea871e82cd4e4553</citedby><cites>FETCH-LOGICAL-c387t-3dc2e109d2f07ea8a848d728a134a33be4352717fb01d43a7ea871e82cd4e4553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17603847$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ksiaa, Leila</creatorcontrib><creatorcontrib>Ayed-Jendoubi, Saloua</creatorcontrib><creatorcontrib>Sfar, Imen</creatorcontrib><creatorcontrib>Gorgi, Yousr</creatorcontrib><creatorcontrib>Najjar, Houda Aouadi Tawfik</creatorcontrib><creatorcontrib>Abdallah, Taieb Ben</creatorcontrib><creatorcontrib>Ayed, Khaled</creatorcontrib><title>Clearance and Persistence of Hepatitis C Virus in a Tunisian Population: Association with HLA Class I and Class II</title><title>Viral Immunology</title><addtitle>Viral Immunol</addtitle><description>Human leukocyte antigens (HLAs) of class I and class II are reported to influence the outcome of hepatitis C virus (HCV) infection. The aim of this study was to assess the role of HLA class I and class II in influencing spontaneous viral clearance or persistence in HCV-infected patients. HLA class I (A and B) typing was performed by lymphocytotoxicity test and HLA class II ( DRB1 ) was determined by low-resolution PCR-SSP (polymerase chain reaction amplification with sequencespecific primers) for 99 subjects (48 men and 51 women). Of these, 75 had chronic infection and 24 had viral clearance. No significant differences were observed between individuals with spontaneous viral clearance or chronic HCV infection for age, sex, source of infection, and risk factors. HLAB-w35 and HLA-DRB1*08 occurred more frequently in those with viral clearance (21.7 and 16.6%, respectively) compared with those with chronic infection (5.5 and 2.6%; p &lt; 0.04 and p &lt; 0.01, respectively). DRB1*15 occurred more often in those with chronic infection (29.3%) compared with those with viral clearance (16.66%), but the difference did not reach statistical significance. These results support the hypothesis that specific HLA class I and class II alleles might influence the clearance or persistence of HCV infection. Both Bw35 and DRB1*08 are associated with clearance of circulating HCV whereas DRB1*15 appears to predispose to progression of liver disease in Tunisian patients. Taken together, our results and those previously reported suggest that HLA associations with the outcome of hepatitis C viremia vary in relation to the ethnicity of the population studied. Further prospective studies of larger cohorts of HCV-infected subjects are needed to evaluate, in different populations, the role of specific HLA class I and class II alleles in the outcome of HCV infection.</description><subject>Aged</subject><subject>Alleles</subject><subject>Brief Report</subject><subject>Female</subject><subject>Genes, MHC Class I</subject><subject>Genes, MHC Class II</subject><subject>Genotype</subject><subject>Hepacivirus - immunology</subject><subject>Hepacivirus - isolation &amp; purification</subject><subject>Hepatitis C virus</subject><subject>Hepatitis C, Chronic - ethnology</subject><subject>Hepatitis C, Chronic - genetics</subject><subject>Hepatitis C, Chronic - immunology</subject><subject>Hepatitis C, Chronic - virology</subject><subject>Histocompatibility Antigens Class I</subject><subject>Histocompatibility Antigens Class II</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Tunisia - epidemiology</subject><subject>Viral Load</subject><issn>0882-8245</issn><issn>1557-8976</issn><issn>1365-2567</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkU1r2zAYgMVYWdN0x12H2GE3p_qyJO8WTNcEAu2h7VUo9mum4siZXnuj_752alrYZQd9vOLhAfEQ8oWzFWe2uPoTDivBmF6Ni30gC57nJrOF0R_JglkrMitUfk4uEJ8YY1Zb-Ymcc6OZtMosSCpb8MnHCqiPNb2DhAF7mOauoRs4-j70AWlJH0MakIZIPb0fYsDgI73rjkM7El38QdeIXRVOA_0b-l90s1vTsvWIdHtyz_ftJTlrfIvweT6X5OHn9X25yXa3N9tyvcsqaU2fyboSwFlRi4YZ8NZbZWsjrOdSeSn3oGQuDDfNnvFaST8xhoMVVa1A5blcku-v3mPqfg-AvTsErKBtfYRuQGeY1row7L8gL4zUhdQj-O0f8KkbUhw_4QQvcq2MECOUvUJV6hATNO6YwsGnZ8eZm5K5MZmbkrkp2ch_naXD_gD1Oz03ehdOzz7GNsAeUv8Gzjozbk5yIV8A_KSf3g</recordid><startdate>20070601</startdate><enddate>20070601</enddate><creator>Ksiaa, Leila</creator><creator>Ayed-Jendoubi, Saloua</creator><creator>Sfar, Imen</creator><creator>Gorgi, Yousr</creator><creator>Najjar, Houda Aouadi Tawfik</creator><creator>Abdallah, Taieb Ben</creator><creator>Ayed, Khaled</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20070601</creationdate><title>Clearance and Persistence of Hepatitis C Virus in a Tunisian Population: Association with HLA Class I and Class II</title><author>Ksiaa, Leila ; Ayed-Jendoubi, Saloua ; Sfar, Imen ; Gorgi, Yousr ; Najjar, Houda Aouadi Tawfik ; Abdallah, Taieb Ben ; Ayed, Khaled</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-3dc2e109d2f07ea8a848d728a134a33be4352717fb01d43a7ea871e82cd4e4553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Aged</topic><topic>Alleles</topic><topic>Brief Report</topic><topic>Female</topic><topic>Genes, MHC Class I</topic><topic>Genes, MHC Class II</topic><topic>Genotype</topic><topic>Hepacivirus - immunology</topic><topic>Hepacivirus - isolation &amp; purification</topic><topic>Hepatitis C virus</topic><topic>Hepatitis C, Chronic - ethnology</topic><topic>Hepatitis C, Chronic - genetics</topic><topic>Hepatitis C, Chronic - immunology</topic><topic>Hepatitis C, Chronic - virology</topic><topic>Histocompatibility Antigens Class I</topic><topic>Histocompatibility Antigens Class II</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Tunisia - epidemiology</topic><topic>Viral Load</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ksiaa, Leila</creatorcontrib><creatorcontrib>Ayed-Jendoubi, Saloua</creatorcontrib><creatorcontrib>Sfar, Imen</creatorcontrib><creatorcontrib>Gorgi, Yousr</creatorcontrib><creatorcontrib>Najjar, Houda Aouadi Tawfik</creatorcontrib><creatorcontrib>Abdallah, Taieb Ben</creatorcontrib><creatorcontrib>Ayed, Khaled</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Viral Immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ksiaa, Leila</au><au>Ayed-Jendoubi, Saloua</au><au>Sfar, Imen</au><au>Gorgi, Yousr</au><au>Najjar, Houda Aouadi Tawfik</au><au>Abdallah, Taieb Ben</au><au>Ayed, Khaled</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clearance and Persistence of Hepatitis C Virus in a Tunisian Population: Association with HLA Class I and Class II</atitle><jtitle>Viral Immunology</jtitle><addtitle>Viral Immunol</addtitle><date>2007-06-01</date><risdate>2007</risdate><volume>20</volume><issue>2</issue><spage>312</spage><epage>319</epage><pages>312-319</pages><issn>0882-8245</issn><eissn>1557-8976</eissn><eissn>1365-2567</eissn><abstract>Human leukocyte antigens (HLAs) of class I and class II are reported to influence the outcome of hepatitis C virus (HCV) infection. The aim of this study was to assess the role of HLA class I and class II in influencing spontaneous viral clearance or persistence in HCV-infected patients. HLA class I (A and B) typing was performed by lymphocytotoxicity test and HLA class II ( DRB1 ) was determined by low-resolution PCR-SSP (polymerase chain reaction amplification with sequencespecific primers) for 99 subjects (48 men and 51 women). Of these, 75 had chronic infection and 24 had viral clearance. No significant differences were observed between individuals with spontaneous viral clearance or chronic HCV infection for age, sex, source of infection, and risk factors. HLAB-w35 and HLA-DRB1*08 occurred more frequently in those with viral clearance (21.7 and 16.6%, respectively) compared with those with chronic infection (5.5 and 2.6%; p &lt; 0.04 and p &lt; 0.01, respectively). DRB1*15 occurred more often in those with chronic infection (29.3%) compared with those with viral clearance (16.66%), but the difference did not reach statistical significance. These results support the hypothesis that specific HLA class I and class II alleles might influence the clearance or persistence of HCV infection. Both Bw35 and DRB1*08 are associated with clearance of circulating HCV whereas DRB1*15 appears to predispose to progression of liver disease in Tunisian patients. Taken together, our results and those previously reported suggest that HLA associations with the outcome of hepatitis C viremia vary in relation to the ethnicity of the population studied. Further prospective studies of larger cohorts of HCV-infected subjects are needed to evaluate, in different populations, the role of specific HLA class I and class II alleles in the outcome of HCV infection.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>17603847</pmid><doi>10.1089/vim.2006.0060</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0882-8245
ispartof Viral Immunology, 2007-06, Vol.20 (2), p.312-319
issn 0882-8245
1557-8976
1365-2567
language eng
recordid cdi_proquest_miscellaneous_19736936
source Wiley Online Library - AutoHoldings Journals; MEDLINE; Wiley Online Library Free Content; IngentaConnect Free/Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Aged
Alleles
Brief Report
Female
Genes, MHC Class I
Genes, MHC Class II
Genotype
Hepacivirus - immunology
Hepacivirus - isolation & purification
Hepatitis C virus
Hepatitis C, Chronic - ethnology
Hepatitis C, Chronic - genetics
Hepatitis C, Chronic - immunology
Hepatitis C, Chronic - virology
Histocompatibility Antigens Class I
Histocompatibility Antigens Class II
Humans
Male
Middle Aged
Prospective Studies
Risk Factors
Tunisia - epidemiology
Viral Load
title Clearance and Persistence of Hepatitis C Virus in a Tunisian Population: Association with HLA Class I and Class II
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T07%3A21%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clearance%20and%20Persistence%20of%20Hepatitis%20C%20Virus%20in%20a%20Tunisian%20Population:%20Association%20with%20HLA%20Class%20I%20and%20Class%20II&rft.jtitle=Viral%20Immunology&rft.au=Ksiaa,%20Leila&rft.date=2007-06-01&rft.volume=20&rft.issue=2&rft.spage=312&rft.epage=319&rft.pages=312-319&rft.issn=0882-8245&rft.eissn=1557-8976&rft_id=info:doi/10.1089/vim.2006.0060&rft_dat=%3Cproquest_cross%3E1304104371%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=219564722&rft_id=info:pmid/17603847&rfr_iscdi=true